Blueprint Medicines (BPMC) Q3 2024 Earnings

1AugConfirmed
Q3 2023
Q4 2023
Q2 2024
Q3 2024
-2.37
-1.1
0.18
1.45

Details

Expected EPS
-1.285791
Actual EPS
-0.8
Surprise EPS
0.49
Surprise Percent
+37.78%

Description

Blueprint Medicines (BPMC) has reported earnings of -0.8 per share for Q3 2024.

0 Comments

Share your thoughts